- Generic name
- Ciprofibrate
- Strength
- 100 mg
- Dosage form
- Tablet
- Manufactured by
- Delta Pharma Limited
CFR Tablet
About CFR 100 mg Tablet
The tablet CFR contains Ciprofibrate and is made by Delta Pharma Limited. Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following: Treatment of severe hypertriglyceridemia with or without low HDL cholesterol.
There are 2 brands of Ciprofibrate listed in Bangladesh.
What is CFR 100 mg Tablet?
CFR 100 mg tablet is a medicine made by Delta Pharma Limited. It also increases levels of HDL cholesterol. There is evidence that treatment with fibrates may reduce coronary heart disease events. Use it only as your doctor directs.
Uses of CFR
Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following: Treatment of severe hypertriglyceridemia with or without low HDL cholesterol. Mixed hyperlipidemia when a statin is contraindicated or not tolerated. Ask your doctor whether it is right for your condition.
How to use CFR
CFR is taken by mouth. Swallow the tablet with water. If you miss a dose, ask your doctor or pharmacist what to do. Do not change the dose or stop early without asking your doctor.
Side effects of CFR
Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
As there are no data on its use in human pregnancy, Ciprofbrate is contraindicated during pregnancy. There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals. As there are no data on its use in lactation, Ciprofbrate is contraindicated in nursing mothers. Keep out of reach of children.
Frequently asked questions
Why is CFR prescribed?
Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following: Treatment of severe hypertriglyceridemia with or without low HDL cholesterol. Mixed hyperlipidemia when a statin is contraindicated or not tolerated.
How should I take CFR?
CFR is taken by mouth. Swallow the tablet with water.
Can CFR cause side effects?
Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue. Tell your doctor if any side effect bothers you or does not go away.
Who should be careful with CFR?
As there are no data on its use in human pregnancy, Ciprofbrate is contraindicated during pregnancy. There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals.
Indications
- Treatment of severe hypertriglyceridemia with or without low HDL cholesterol.
- Mixed hyperlipidemia when a statin is contraindicated or not tolerated.
Pharmacology
Dosage & Administration
Patients with renal insufficiency: In moderate renal impairment (creatinine clearance 30-80 ml/min/1.73 m2) it is recommended that dosage be reduced to one tablet every other day. Patients should be carefully monitored. Ciprofbrate should not be used in severe renal impairment (creatinine clearance <30 ml/min/1.73 m2).
Patients with hepatic insufficiency: Use with caution in patients with impaired hepatic function. Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.
Elderly: As for adults but precautions should be taken for Age more than 70 years.
Paediatric population: Not recommended since safety and efficacy in children has not been established.
Interaction
Oral anticoagulant therapy: Caution should be exercised when Ciprofbrate is taken with oral anticoagulants. Concomitant oral anticoagulant therapy should be given at a reduced dosage and adjusted according to INR.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients
- Severe hepatic impairment
- Severe renal impairment (creatinine clearance <30 ml/min/1.73 m2)
- Pregnancy and lactation or when pregnancy is suspected
- Concurrent use with another fibrate
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Myalgia/myopathy: Patients should be advised to report unexplained muscle pain, tenderness or weakness immediately.
Patients with impaired hepatic function: Periodic hepatic function tests are recommended (every 3 months for the first 12 months of treatment). Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.
Storage Conditions
Alternative brands of Ciprofibrate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.